U.S. Stock News

Ever wondered if Smithfield Foods is as undervalued as some claim? Let’s take a closer look at whether the current share price really offers a bargain for smart investors like you. The stock has nudged up by 3.0% over the past week. It has dipped 5.3% in the last 30 days, but still manages a robust 12.2% gain year-to-date. This hints at shifting sentiment and growth potential. Recent headlines have focused on Smithfield Foods' moves in expanding its plant-based protein product line and...

Carlisle Companies (CSL) reported current net profit margins of 15.3%, down from 17.8% a year ago, highlighting the impact on profitability. Over the past five years, earnings grew at an annual pace of 18.3%. However, forward guidance points to a more tempered 6.7% annual increase in earnings and 3.3% revenue growth. Shares currently trade at $325.05, below the estimated fair value of $363.83, with a Price-to-Earnings Ratio of 18x, which trails both the industry and peer averages. Investors...

Merit Medical Systems (MMSI) posted net profit margins of 8.3%, down from 9% last year, while earnings advanced just 1.4%, well below its five-year average of 40.5% annual growth. With the company’s Price-to-Earnings Ratio sitting at 43.5x, a premium over both peer and industry averages, and the stock trading slightly above the estimated fair value of $85.48 per share, investors may be weighing whether current lofty valuations can be sustained. Forecasts indicate earnings growth could...

Curious if Synovus Financial is a hidden bargain or well-valued at its current price? Dive in as we break down what drives its value. There may be more to the story than meets the eye. While the stock is up an impressive 106.1% over the past five years, shorter-term performance has been more volatile, with a -3.1% return in the last week, -8.3% over the last month, and -12.2% year-to-date. Recent headlines have highlighted Synovus Financial’s ongoing digital transformation efforts and its...

Wondering whether CVR Partners stock could be undervalued, overvalued, or finally primed for something big? You are definitely not alone in wanting to figure out whether now is the right time to take a closer look. The stock has not just stayed afloat but surged, climbing 1.3% in the last week, 5.0% over the past month, and a staggering 60.2% in the past year. This performance has made many investors sit up and pay attention. Recent news around the fertilizer industry, such as shifting...

Houlihan Lokey (HLI) posted 32.6% earnings growth in the most recent year, a sharp acceleration from its 1% average annual pace over the past five years. Revenue is forecast to climb by 11.2% per year, outpacing the US market’s 10.3% growth outlook. Net profit margins have risen to 16.5% from last year’s 15.3%. Investors may see the combination of high quality earnings and improved profitability as encouraging, but a price-to-earnings ratio of 30.8x and share price of $179.08 put valuation...

Estée Lauder Companies (EL) is trading below its estimated fair value of $116.16, with shares last noted at $96.69. The company’s Price-to-Sales ratio sits at 2.4x, on par with peers but more expensive than the broader US Personal Products industry average of 1.1x. Revenue is forecast to grow at 3.9% per year, lagging behind the broader US market’s 10.4% pace. Although losses have deepened at a 47.6% annual rate over the last five years, earnings are expected to grow 47.57% annually as the...

Savers Value Village (SVV) remains unprofitable, with reported losses widening at a pace of 4.1% per year over the past five years. Revenue is projected to grow 7.6% annually, trailing the broader US market's 10.3%, but forecasts call for a striking 100.7% annual increase in earnings, with profitability expected within three years. Currently trading at $9.21, which is below its estimated fair value and industry peers, SVV stands out for its attractive valuation despite ongoing financial...

Motorola Solutions (MSI) turned in a sharp jump in profitability this quarter, with net profit margins rising to 18.7% from 14.7% a year ago and earnings growing by 35.6% over the last year, well above the company’s five-year average pace. Looking ahead, consensus calls for earnings to increase at a steadier 9.09% per year and revenue to grow at 6.8% annually, both trailing broader US market averages. Investors are seeing ongoing improvements in profitability, balanced with expectations for...

Cardinal Health (CAH) booked another strong year of profit growth, with earnings rising 24.6%, well above its five-year average of 18% per year. Net profit margins also ticked higher to 0.7%, up from 0.6% a year ago, while the forecast calls for 10.7% annual earnings growth. With the stock trading at 28.4x earnings, above its peer and industry averages, investors are left weighing steady profit gains against a premium valuation and modest revenue growth forecasts. See our full analysis for...

Wondering if ACADIA Pharmaceuticals is actually good value right now? You’re not alone, and we’re going to dig into what the numbers really show. The stock has jumped 3.1% in the past week and is up a striking 53.3% over the last year, putting growth potential and risk back in the spotlight for current and prospective investors. There has been a flurry of activity around ACADIA lately, with new product launch updates and expanded regulatory approvals giving investors more to think about...

Radware Ltd. recently reported strong third-quarter earnings, with revenue rising to US$75.31 million and net income increasing to US$5.65 million compared to the same period last year. An interesting highlight was the company's 24% year-over-year growth in cloud annual recurring revenue, reflecting sustained demand for its AI-powered security offerings. We’ll look at how Radware’s accelerated cloud revenue growth shapes its broader investment narrative in security technology. Rare earth...

Weyerhaeuser (WY) saw net profit margins fall to 4%, down from 9.9% in the previous year, as the company’s earnings have declined by 25.8% annually over the past five years. Despite these historical pressures, the share price of $23 is well below the estimated fair value of $95.70, and the company is forecast to deliver robust profit growth, with earnings projected to jump 46.2% annually in the next three years, outpacing the US market’s expected 15.9% growth. The numbers underscore a...

Gilead Sciences (GILD) posted headline-grabbing earnings growth of 6,336.5% year-over-year, far outpacing its 5-year average growth rate of 8.2% per year. Net profit margins recovered sharply to 27.9% from last year’s minimal 0.4%, offering a robust margin story for shareholders. While earnings are projected to grow at 9.1% annually and revenue at 4.5% per year going forward, investors will be weighing this momentum against the broader and faster-growing US market. See our full analysis for...

Wondering if J. M. Smucker is priced right for your portfolio or if the market has it all wrong? You are not alone, and getting the valuation right can make all the difference. The stock has seen its ups and downs lately, ticking up 1.4% over the past week but still down 4.6% in the last month and 7.0% so far this year. Recent headlines have centered around the shifting landscape in consumer staples, with bigger trends in food inflation and shifting consumer preferences...

NPK International (NPKI) has delivered consistent profitability over the past five years, with earnings growing at an impressive 74% per year during that time. Looking ahead, analysts expect revenue to expand at 8.9% per year, slightly lagging the US market average of 10.3%. EPS is projected to rise by a robust 20.2% each year, outpacing the national benchmark. While recent net profit margin slipped to 12.8% from last year’s 15.9% and earnings growth slowed to 1.7%, the company’s historical...

Chevron (CVX) reported revenue growth forecasts of just 0.5% per year, trailing the broader US market’s 10.4% pace. Net profit margins have declined to 7.2% from 9.6% a year ago, and earnings have seen negative growth over the past year compared to the company’s five-year average. While analysts project earnings will grow at about 13% annually moving forward, this remains below the estimated 15.9% rate for the wider US market. Investors are weighing these slower growth signals and margin...

Thinking about whether Fidelity National Information Services is actually a bargain right now? You are not alone, and this question has plenty of investors curious given its recent market moves. Fidelity National Information Services shares have had quite a ride, dropping 7.8% in the past week and sinking 21.9% since the start of the year. This has definitely shifted the conversation about its potential and risk profile. Industry chatter has been growing around digital payments and the...

Columbia Banking System (COLB) posted a net profit margin of 28.2% for the most recent period, up from 25.6% last year, and has delivered earnings growth averaging 42.8% per year over the past five years. The company is forecast to grow EPS by 26.4% annually and revenue by 11% per year, both outperforming the broader US market benchmarks. This combination of accelerating margins, forecasted growth, and strong historical performance puts the spotlight on Columbia Banking System’s current...

China Yuchai International announced that Mr. Wu Qiwei resigned as a Director, effective October 27, 2025, from both the company and its main operating subsidiary, Guangxi Yuchai Machinery Company Limited. The resignation came after reports that Mr. Wu is under investigation for serious violations of discipline and law, raising questions about the company’s governance and leadership stability. We will assess how the director resignation amid legal investigation could influence China Yuchai...

ResMed (RMD) posted impressive numbers with net profit margins climbing to 27.4% from 23.1% a year ago, and EPS advancing 29.2% year-over-year. Over the last five years, earnings have grown at a robust 19.8% annually, though forecasts call for a slower pace with 8.8% earnings and 7.1% revenue growth per year, both trailing US market averages. Despite moderation in projected growth, the latest results highlight ResMed’s consistent profit expansion, high-quality earnings, and valuation...

Aon (AON) continued its run of profit growth, reporting that earnings have climbed by 11.1% per year over the past five years. Looking ahead, the company expects earnings to rise at a slower pace of 10.7% annually, which trails both its own historical average and broader US market forecasts. Although revenue is projected to grow at 5% per year, this too lags behind the US market, and a dip in net profit margin to 15.5% from last year’s 18% highlights some pressure on profitability. See our...

AbbVie (ABBV) reported a net profit margin of 6.4% for the twelve months through September 2025, down from 9.6% a year earlier, as its bottom line took a hit from a major one-off loss of $14.5 billion. Over the past five years, average annual earnings have declined by 11.5%, although forecasts now point to a rebound, with revenue expected to grow 6.8% per year and earnings growth projected at around 16% annually, just ahead of the broader market. This blend of near-term weakness and long-term...

Some Steel Dynamics, Inc. ( NASDAQ:STLD ) shareholders may be a little concerned to see that the Senior Vice President...